MedPath

TO STUDY THE EFFECT OF CLASSICAL DHUMA NASYA AND MODIFIED DHUMA NASYA (IN THE FORM OF NEBULIZATION) IN TAMAKA SWASA(BRONCHIAL ASTHMA)

Phase 2
Conditions
Health Condition 1: J069- Acute upper respiratory infection,unspecifiedHealth Condition 2: J22- Unspecified acute lower respiratory infection
Registration Number
CTRI/2022/11/047309
Lead Sponsor
Dr Vibha Chauhan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.patients age between 20-50 years irrespective of caste, race gender .

2.The patient having classical signs and symptoms of tamakaswasa.

3.PEFR 60%-90% (PEAK EXPIRATORY FLOW RATE )

Exclusion Criteria

1.The patient with chronic respiratory disease like history of tuberculosis, emphysema,pulmonary effusion COPD other complicated respiratory disease such as tumor or any anatomical defect in airways.

2. pregnant and lactating woman.

3. severe and systemic diseases like uncontrolled hypertention uncontrolled diaebets

4. CKD (chronic kidney disease ) severe chronic metabolic disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
25% unchanged <br/ ><br>25-50% mild improvement <br/ ><br>50-75% moderate improvement <br/ ><br>75% marked improvementTimepoint: 10th 20th 30th days
Secondary Outcome Measures
NameTimeMethod
exacerbation in sign and symptomsTimepoint: 2 months
© Copyright 2025. All Rights Reserved by MedPath